These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 4135410)
21. Active or passive enhancement and allograft survival. Wilson RE Transplant Proc; 1972 Dec; 4(4):513-5. PubMed ID: 4405144 [No Abstract] [Full Text] [Related]
28. Unsuccessful attempts to control hyperacute rejection of human renal homografts with F(ab') 2 and citrate organ pretreatment. Corman JL; Kashiwagi N; Porter KA; Andres G; Iwatsuki S; Putnam CW; Popovtzer M; Penn I; Starzl TE Transplantation; 1973 Jul; 16(1):60-3. PubMed ID: 4576857 [No Abstract] [Full Text] [Related]
30. The efficacy of bolus doses of intravenous methylprednisolone (MPIV) in the treatment of acute renal allograft rejection. Kountz SL; Rao TK; Butt KH Transplant Proc; 1975 Mar; 7(1):73-7. PubMed ID: 1091048 [No Abstract] [Full Text] [Related]
31. Renal transplantation in the rabbit. I. Development of a model for study of hyperacute rejection and immunological enhancement. Holter AR; McKearn TJ; Neu MR; Fitch FW; Stuart FP Transplantation; 1972 Mar; 13(3):244-9. PubMed ID: 4112148 [No Abstract] [Full Text] [Related]
32. Control of humoral rejection of renal allografts in presensitized monkeys by monospecific F(ab')2 fragments. Kahan MG; Martins AC; Macpherson SG; Wren SF; Busch GJ; Wilson RE Surg Forum; 1975; 26():311-3. PubMed ID: 814638 [No Abstract] [Full Text] [Related]
33. Comparison of medroxyprogesterone and corticosteroids in the treatment of canine renal allografts. Macdonald AS; Falvey CF; Chan CC Can J Surg; 1972 Sep; 15(5):326-31. PubMed ID: 4560407 [No Abstract] [Full Text] [Related]
34. Rejection crises in human renal transplant recipients: control with high dose methylprednisolone therapy. Turcotte JG; Feduska NJ; Carpenter EW; McDonald FD; Bacon GE Arch Surg; 1972 Aug; 105(2):230-6. PubMed ID: 4557979 [No Abstract] [Full Text] [Related]
35. Immunologic injury induced by ex vivo perfusion of canine renal autografts. Filo RS; Dickson LG; Suba EA; Sell KW Surgery; 1974 Jul; 76(1):88-100. PubMed ID: 4601595 [No Abstract] [Full Text] [Related]
36. The renal xenograft rejection. Effect of hyperimmune F(ab') 2 and succinylated IgG. Habal MB; Misra MK; Busch GJ; Carpenter CB; Birtch AG Transplantation; 1972 Dec; 14(6):796-8. PubMed ID: 4566275 [No Abstract] [Full Text] [Related]
37. Remarkable recovery from rejection by treatment with deoxyspergualin and methylprednisolone on canine kidney allografts. Suzuki S; Hayashi R; Niiya S; Kenmochi T; Fukuoka T; Amemiya H Transplant Proc; 1991 Feb; 23(1 Pt 1):545-6. PubMed ID: 1990606 [No Abstract] [Full Text] [Related]
38. Enhanced survival of canine renal allografts of ALS- treated dogs given bone marrow. Caridis DT; Liegeois A; Barrett I; Monaco AP Transplant Proc; 1973 Mar; 5(1):671-4. PubMed ID: 4572126 [No Abstract] [Full Text] [Related]
39. Corticosteroids in immunosuppression: partial fulfillment of a promise. Friedman EA Transplant Proc; 1975 Mar; 7(1):1-3. PubMed ID: 164066 [No Abstract] [Full Text] [Related]
40. Inhibition of renal allograft rejection. Instances in dogs with specific enchancing immunoglobulin and its proteolytic fragments. Yonemoto RH; Deliman RM; DuSold WD; Hamilton T Arch Surg; 1973 Sep; 107(3):390-4. PubMed ID: 4593193 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]